LEIDEN, Netherlands, January 4, 2018 /PRNewswire/ --
Bondholders convert €7.7 million of their remaining bonds into Pharming Shares and cash
Further reduction in net debt and interest payments
Cash balance following conversion (prior to year-end) was €56.0 million&nb... |